Clinically relevant RSV anti-F antibodies exhibit comparable inhibition of syncytium formation despite marked differences in neutralization potency

Lotte T. Azink, Thomas Boonstoppel, Daniel Ramírez Alfaro, Claudia van Hal, Emmanuel J. H. J. Wiertz, Robert Jan Lebbink

Open source

DOI
10.1128/jvi.01155-26
Published
2026-11-06
Container
Journal of Virology
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/jvi.01155-26,
  title = {Clinically relevant RSV anti-F antibodies exhibit comparable inhibition of syncytium formation despite marked differences in neutralization potency},
  author = {Lotte T. Azink and Thomas Boonstoppel and Daniel Ramírez Alfaro and Claudia van Hal and Emmanuel J. H. J. Wiertz and Robert Jan Lebbink},
  year = {2026},
  journal = {Journal of Virology},
  doi = {10.1128/jvi.01155-26},
  url = {https://doi.org/10.1128/jvi.01155-26}
}

RIS

TY  - JOUR
TI  - Clinically relevant RSV anti-F antibodies exhibit comparable inhibition of syncytium formation despite marked differences in neutralization potency
AU  - Lotte T. Azink
AU  - Thomas Boonstoppel
AU  - Daniel Ramírez Alfaro
AU  - Claudia van Hal
AU  - Emmanuel J. H. J. Wiertz
AU  - Robert Jan Lebbink
PY  - 2026
JO  - Journal of Virology
DO  - 10.1128/jvi.01155-26
UR  - https://doi.org/10.1128/jvi.01155-26
ER  - 

APA

Azink, L. T., Boonstoppel, T., Alfaro, D. R., Hal, C. V., Wiertz, E. J. H. J., & Lebbink, R. J. (2026). Clinically relevant RSV anti-F antibodies exhibit comparable inhibition of syncytium formation despite marked differences in neutralization potency. Journal of Virology. https://doi.org/10.1128/jvi.01155-26

Source records